Phenocure's commercial strategy will be focused in generating revenue from 3 main areas:

1. PFR based partnerships
Partnership based licensing and collaborations with leading Pharmaceutical companies to apply PFR based Drug discovery technologies in key high-need therapeutic areas, alternative to gene therapy.

2. PhenoCure's internal Drug pipeline
PhenoCure has applied PFR technologies to discover a drug compound - CC1 - which is a potential cure for Bone and Colon cancers. PhenoCure intends to apply PFR discovery technologies to other high need therapeutic areas.

3. Foldase based partnerships and projects - functional proteins and associated technologies
Partnership based licensing and collaborations with leading Pharmaceutical companies to apply Foldase protein expression technologies to enhance and accelerate protein expression stages within the drug discovery process.

The commercial and Research & Development activities of PhenoCure will result in the company building value by consolidating existing proprietary technologies and therapeutics, developing further therapeutics and by making further technical advances to simultaneously grow its short, medium, and long term revenue streams.